Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Colorcon
Express Scripts
Dow
AstraZeneca

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019141

See Plans and Pricing

« Back to Dashboard

NDA 019141 describes BETAMETHASONE DIPROPIONATE, which is a drug marketed by Anda Repository, Fougera Pharms, Glenmark Generics, Perrigo Israel, Taro, Acp Nimble, Actavis Mid Atlantic, Perrigo New York, Pharmaderm, Teva, Zydus Pharms, Hi Tech, Teligent Pharma Inc, Alpharma Us Pharms, and Fougera Pharms Inc, and is included in forty-one NDAs. It is available from twenty-one suppliers. Additional details are available on the BETAMETHASONE DIPROPIONATE profile page.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 019141
Tradename:BETAMETHASONE DIPROPIONATE
Applicant:Fougera Pharms Inc
Ingredient:betamethasone dipropionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019141
Suppliers and Packaging for NDA: 019141
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019141 NDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0056 0168-0056-15 1 TUBE in 1 CARTON (0168-0056-15) > 15 g in 1 TUBE
BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019141 NDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0056 0168-0056-46 1 TUBE in 1 CARTON (0168-0056-46) > 45 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrengthEQ 0.05% BASE
Approval Date:Sep 4, 1984TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
McKinsey
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.